If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

20 Jan 2005 07:00

Torex Retail PLC20 January 2005 20th January 2005 Torex Retail plc expands UK Petroleum Business with £2.1m acquisition of Petroleum Services Business Torex Retail plc ("Torex Retail"), the UK's market leader in retail IT systems,today announces the completion of the £2.1m acquisition of Flexiline ForecourtServices Limited ("Flexiline"). Flexiline specialises in the installation andservicing of equipment in petrol filling stations. The £2.1m consideration willbe satisfied by the payment of £1.05m in cash and £1.05m by the issue of1,288,343 new Torex Retail shares. Flexiline, based in Hertfordshire, provides a range of forecourt servicesincluding the project management of service station redevelopment, petrol pumpand system refurbishment, forecourt equipment installation and servicing. Thecompany has grown steadily through winning significant service contracts frommajor retailing groups and achieved sales of £2.5m for the 12 months ended 31stOctober 2004. Flexiline will become part of Torex Retail's expanding Petroleum and ConvenienceDivision and will complement the range of products and services provided for theUK retail petroleum market. Rob Loosemore, Executive Chairman of Torex Retail plc, commented: "The acquisition of Flexiline will add depth to our service offering in theretail petroleum sector. Over the next few years there will be increaseddevelopment and refurbishment activity on forecourts with the introduction ofnew fuels, environmental protection legislation and the addition of outdoorpayment terminals on forecourts. We will now be even better placed to takeadvantage of this increased activity. Flexiline has established an enviable reputation in the market and I expectthat, with the backing of Torex Retail, the company will be in a better positionto win new business from major oil companies. The market is dominated by theservice departments of pump companies and there is no independent company sowell equipped as Flexiline to offer high quality service on the full range ofequipment at filling stations." - ends - Enquiries: Torex Retail plc Citigate Dewe RogersonRob Loosemore, Executive Chairman Seb Hoyle / Ginny PulbrookRichard Thompson, Finance Director Freida MooreTelephone: +44 (0) 870 050 9900 Telephone: +44 (0) 20 7638 9571 Application will be made for the 1,288,343 new shares to be issued pursuant tothe consideration for the acquisition to be admitted to trading on AIM.Admission is expected to become effective on 25 January 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Oct 20167:00 amRNSInterim Results
28th Sep 20167:00 amRNSNotice of Interim Results
15th Sep 20163:07 pmRNSEdison issues outlook on Tissue Regenix
1st Sep 20167:00 amRNSDermaPure® Medicare coverage in further 10 States
3rd Aug 20167:15 amRNSHardman & Co Research Report on: Tissue Regenix
28th Jul 201610:58 amRNSEdison research outlook on Tissue Regenix (TRX)
18th Jul 201611:20 amRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
11th Jul 20167:00 amRNSOrthopaedics Update
4th Jul 201610:41 amRNSResult of AGM
1st Jul 20167:00 amRNSDermaPure® secures first GPO contract in US
30th Jun 20167:00 amRNSDeferred Annual Bonus Scheme
1st Jun 20167:00 amRNSNew appointment adds clinical expertise to Board
23rd May 20167:00 amRNSPreliminary results for year ended 31 January 2016
20th Apr 20167:00 amRNSNotice of Preliminary Results
14th Apr 20167:00 amRNSChange of Registered Office
24th Mar 20164:40 pmRNSSecond Price Monitoring Extn
24th Mar 20164:35 pmRNSPrice Monitoring Extension
11th Mar 20163:02 pmRNSTR1- NOTIFICATION OF MAJOR INTEREST IN SHARES
9th Mar 20167:00 amRNSFurther Medicare Coverage for DermaPure®
9th Mar 20167:00 amRNS510k market clearance granted for SurgiPureT XD
11th Feb 20167:00 amRNSVP, Orthopaedic, Inc. North America appointed
3rd Feb 20167:00 amRNSDermaPure to be Showcased in Nine Posters at SAWC
26th Jan 201612:21 pmRNSJoint Venture Agreement
25th Jan 20167:00 amRNSHardman & Co Research Report
20th Jan 20167:00 amRNSDermaPure® breaks through $1m sales mark
19th Jan 20167:00 amRNSAppointment of Non-Executive Director
18th Jan 20167:00 amRNSOrthoPureT XM clinical trial enrolment completed
23rd Dec 201512:40 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
4th Dec 20157:00 amRNSOrthoPureT XT implants successfully undertaken
5th Nov 20154:42 pmRNSIssue of equity and total voting rights
26th Oct 20157:00 amRNSIssue of equity and total voting rights
23rd Oct 20157:49 amRNSNon-Executive Director Share Purchase
14th Oct 20154:09 pmRNSEdison initiates coverage of Tissue Regenix
12th Oct 20157:00 amRNSInterim Results
4th Sep 201510:11 amRNSNotice of Interim Results and Capital Markets Day
30th Jul 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure
22nd Jul 20157:00 amRNSAdditional US regional distribution agreement
26th Jun 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure®
12th Jun 201512:43 pmRNSResult of AGM
1st Jun 20159:17 amRNSDermaPure saves 18 year old's leg from frost bite
21st May 20159:51 amRNSHolding(s) in Company
20th May 20157:00 amRNSEmployee SAYE Share Plan
12th May 20157:00 amRNSDeferred Annual Bonus Award
11th May 20157:00 amRNSFinal Results
11th May 20157:00 amRNSFurther Medicare Coverage Approval for DermaPure
5th May 20157:02 amRNSUS regional distribution agreement signed
1st May 20154:01 pmRNSHolding(s) in Company
29th Apr 20157:01 amRNSDermaPure US Clinical data to be presented at SAWC
28th Apr 20157:00 amRNSOrthoPureT XT (Tendon) UK Clinical Trial Approval
9th Mar 20152:05 pmRNSNotice of Preliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.